Prime Medicine, known for its goal of treating hundreds of diseases with CRISPR, says it's narrowing its focus to two. It ...

The gene editing company CRISPR Therapeutics surprisingly struck a deal with China-based biotech Sirius Therapeutics to ...

Durham-based Atsena Therapeutics has received Regenerative Medicine Advanced Therapy (RMAT) designation from the U.S. Food and Drug Administration (FDA) for ATSN-201, its gene therapy product for the ...

In its announcement of the acquisition, Regeron claimed it would ensure that customers’ personal data including genetic and ...

Schrödinger is laying off 60 staffers, or about 7% of its workforce, in an effort to save cash and boost efficiency. | ...

A Massachusetts-based wound care and sports medicine company announced plans for its brand-new biomanufacturing facility ...

"While the rescinded grant is undoubtedly a setback, it also sharpens our focus on the solid foundation already established ...

Viking Therapeutics offers leaner operations, lower complexity, faster trial execution, and less execution risk. Learn more ...

Biotech firm Synthego files for bankruptcy despite a purchase agreement with Perceptive Advisors and plans for operational ...

Discover seven lung cancer companies advancing promising candidates through the clinic, from viral immunotherapies to ...

Debates over AI antibody design terminology have clouded the industry’s shared mission of bringing better therapeutics to the ...

In the Phase 2 study of patients with chronic kidney disease, the highest dose of the drug lowered by 86% the levels of ...